Skip to main content

Theratechnologies Inc(THTX-Q)
NASDAQ

Today's Change
Delayed Last Update

Theratechnologies Inc

2015 Peel Street 11th Floor
MONTREAL A8 H3A 1T8 CAN
P: 438-315-6607
F: 514-331-9691
http://www.theratech.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is marketed primarily in the United States, Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, and Thailand. Theratechnologies, Inc. is headquartered in Montreal, Canada.

    Key Executives

    NameTitle
    Christian MarsolaisChief Medical Officer/Senior VP
    Marie-Noel ColussiVice President, Divisional
    Jocelyn LafondGeneral Counsel/Secretary
    Philippe DubucCFO/Senior VP
    Paul LevesqueCEO/Director/President
    Andre DuprasVice President, Divisional
    John LeasureOther Corporate Officer

    More from The Globe